County
Stanly County EMS
The current listed document is more than 24 months old and may be outdated.
Drugs and doses43
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate, Cefazolin10
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg | PO | not captured | standing | page 32 |
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 32 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 32 |
| Mild to moderate pain | adult | 15 mg/kg | PO | not captured | standing | page 33 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 33 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 33 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 155 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 182 |
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | page 66 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 182 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5–5 mg | NEB | not captured | standing | page 90 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 94 |
| Respiratory distress | adult | 2.5–5 mg | NEB | not captured | standing | page 108 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 62 |
| Mild to moderate pain | adult | 324–650 mg | PO | not captured | standing | page 33 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.02 mg/kg | IV/IO | not captured | standing | page 177 |
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 58 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 177 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 157 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 169 |
| Other | adult | 8 mg | SL | not captured | standing | page 169 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | page 94 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 94 |
| Hyperkalemia | adult | 20 mg/kg | IV/IO | not captured | standing | page 129 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 129 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 94 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 131 |
D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Fentanyl8
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 0.15 mg/kg | IV/IO/IM | not captured | standing | page 196 |
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | page 98 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 125 mL | IV/IO | not captured | standing | page 92 |
| Hypoglycemia | adult | 5 mL/kg | IV/IO | not captured | standing | page 193 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 193 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 66 |
| Narrow-complex tachycardia | adult | 0.35 mg/kg | IV/IO | not captured | standing | page 66 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | PO | not captured | standing | page 191 |
| Allergic reaction | adult | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 191 |
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 90 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 90 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 191 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 191 |
| Dystonic reaction | adult | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 46 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 46 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 46 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | page 21 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 90 |
| Bradycardia | adult | 1–2 mcg | IV/IO | not captured | standing | page 58 |
| Cardiac arrest | adult | 0.01 mg/kg | IV/IO | not captured | standing | page 175 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 56 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 175 |
| Hypotension / shock | adult | 0.1 mcg/kg | IV/IO | not captured | standing | page 195 |
| Hypotension / shock | adult | 10 mcg | IV/IO | not captured | standing | page 97 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV/IO | not captured | standing | page 195 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 106 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 33 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 33 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 33 |
G–L Glucagon, Hydrocortisone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 0.1 mg/kg | IM | not captured | standing | page 193 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | page 92 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 193 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 98 |
| Adrenal crisis | adult | 50 mg | IV/IO/IM | not captured | standing | page 98 |
| Adrenal crisis | peds | 25 mg | IV/IO/IM | not captured | standing | page 98 |
| Adrenal crisis | peds | 50 mg | IV/IO/IM | not captured | standing | page 98 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 146 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 10 mg/kg | PO | not captured | standing | page 32 |
| Fever | adult | 400–600 mg | PO | not captured | standing | page 32 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 32 |
| Mild to moderate pain | adult | 10 mg/kg | PO | not captured | standing | page 33 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 33 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 33 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | NEB | not captured | standing | page 90 |
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 108 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 2 mg/kg | IM | not captured | standing | page 49 |
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 49 |
| Hyperactive delirium | peds | 2 mg/kg | IM | not captured | standing | page 49 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 33 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 106 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | page 106 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg/kg | IV/IO/IM | not captured | standing | page 33 |
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 33 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 33 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO/IM | not captured | standing | page 33 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 99 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 241 |
| Mild to moderate pain | adult | 20–50 mg | IV/IO | not captured | standing | page 241 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 241 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV/IO | not captured | standing | page 68 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 70 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 72 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | page 68 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 70 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 72 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nicardipine, Nitroglycerin, Norepinephrine, Ondansetron, Oxymetazoline, Oxytocin11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | page 108 |
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | page 202 |
| Respiratory distress | peds | 2 g | IV/IO | not captured | standing | page 202 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 70 |
| VF / pulseless VT | adult | 40 mg/kg | IV/IO | not captured | standing | page 186 |
| VF / pulseless VT | peds | 40 mg/kg | IV/IO | not captured | standing | page 186 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 90 |
| Anaphylaxis | adult | 2 mg/kg | IV | not captured | standing | page 191 |
| Anaphylaxis | peds | 2 mg/kg | IV | not captured | standing | page 191 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 108 |
| Respiratory distress | adult | 2 mg/kg | IV/IO/IM | not captured | standing | page 202 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 202 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 48 |
| Agitation | adult | 10 mg | IM | not captured | standing | page 49 |
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 48 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 48 |
| Mild to moderate pain | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 33 |
| Procedural sedation | adult | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 182 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO | not captured | standing | page 66 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 182 |
| Seizure | adult | 0.2 mg/kg | IM | not captured | standing | page 37 |
| Seizure | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 37 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 37 |
| Seizure | adult | 2–2.5 mg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 37 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 37 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 33 |
| Mild to moderate pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 33 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 33 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.1 mg/kg | IN | not captured | standing | page 60 |
| Opioid overdose | adult | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 60 |
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 60 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | page 60 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 60 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 60 |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IO | not captured | standing | page 99 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3 mg | SL | not captured | standing | page 62 |
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 62 |
| CHF / pulmonary edema | adult | 0.3 mg | SL | not captured | standing | page 64 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 64 |
| CHF / pulmonary edema | adult | 400 mcg | IV | not captured | standing | page 64 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 4–8 mcg | IV/IO | not captured | standing | page 58 |
| Hypotension / shock | adult | 4–8 mcg | IV/IO | not captured | standing | page 97 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 21 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 31 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 118 |
P–R Pralidoxime, Rocuronium2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 157 |
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 157 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 157 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 106 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 94 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 155 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 106 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 134 |
Cite this
Stanly County EMS, United States EMS Protocol Census. 148 dose entries, effective 2024-10-15.
https://protoquiz.com/census/agencies/stanly-county-ems/
The census is free and not for sale. Only public agencies are named.